FDA Inspection
Mid-Missouri Reproductive Med & Srgry IncMid-Missouri Reproductive Med & Srgry Inc – FDA Inspection, Jun 15, 2018
Record Details
This FDA Inspection record concerns Mid-Missouri Reproductive Med & Srgry Inc, with an inspection on June 15, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a9d15c71-d15a-4a50-bae5-aefd197de272
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1056036
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mid-Missouri Reproductive Med & Srgry Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 6, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 1, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 5, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 17, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Mid-Missouri Reproductive Med & Srgry Inc
- FDA Inspection 1226729 - 2023-12-06
- FDA Inspection 951686 - 2015-12-01
- FDA Inspection 894375 - 2014-09-05
- FDA Inspection 712067 - 2011-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.